SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001842952-22-000038
Filing Date
2022-04-04
Accepted
2022-04-04 16:13:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A contexttherapeuticsdefa14aa.htm DEFA14A 11829
2 contexttherapeuticsinc_v001.jpg GRAPHIC 155942
3 contexttherapeuticsinc_v002.jpg GRAPHIC 86206
  Complete submission text file 0001842952-22-000038.txt   346574
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40654 | Film No.: 22802319
SIC: 2834 Pharmaceutical Preparations